Details of the Drug
General Information of Drug (ID: DMZVLY8)
| Drug Name |
Nadrolone phenylpropionate
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Nandrolone phenpropionate; nandrolone phenylpropionate; 62-90-8; Nortestosterone phenylpropionate; Nandrolon phenylpropionate; Nadrolone phenylpropionate; Nerobolil; Fenobolin; Nandrolin; Norandrostenolone phenylpropionate; Superanabolon; Phenobolin; Norandrolone phenyl propionate; NTPP; Durabolin; Durabol; 19Ntpp; Norandrolone phenylpropionate; Nandrolone Phenylpionate; Nerobil; Activin; UNII-KF7Z9K2T3W; Nandrobolic; Anticatabolin; Strabolene; KF7Z9K2T3W; Sintabolin; Equibolin; Norandrol; Anabosan; Hybolin; CHEBI:7468; Nandrolone phenpro
|
||||||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||||||
| Affected Organisms |
Humans and other mammals
|
||||||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||||||||||
| Repurposed Drugs (RPD) | Click to Jump to the Detailed RPD Information of This Drug | ||||||||||||||||||||||||||

